Leveraging EPR effect, the nanomicellar form of WIP2W, referred to as M—WIP2W, exhibits enhanced intra-tumoral accumulation in WT1+ CML mice as compared to free WIP2W, leading to effective inhibition of tumor growth. The gene discussed is WT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.